{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:31:13Z","timestamp":1765780273190,"version":"3.48.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Drug use is a significant risk factor for infectious diseases, yet a comprehensive global assessment of this burden\u2014encompassing trends, inequalities, and forecasts\u2014is lacking, hindering progress toward World Health Organization (WHO)\u2019s 2030 elimination targets. This study provides the first such analysis, leveraging the Global Burden of Disease (GBD) 2021 study to quantify the specific burden of infectious diseases attributable to drug use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using data from 204 countries and territories in the GBD 2021 study, we analyzed deaths and disability-adjusted life years (DALYs) from HIV\/AIDS, sexually transmitted infections (STIs), and other infectious diseases (primarily acute hepatitis B and C) attributable to drug use, following the GBD risk attribution framework. Methods included trend analysis, health inequality assessment, driver decomposition, age-period-cohort modeling, and Auto-Regressive Integrated Moving Average (ARIMA) forecasting to 2036.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1990 to 2021, the global age-standardized mortality rate (ASMR) for HIV\/AIDS and STIs attributable to drug use increased by 135%, peaking around 2005 before declining, while the ASMR for other infectious diseases decreased by 57%. Males aged 30\u201354 carried the highest burden. Health inequality analysis revealed a shift of HIV\/AIDS and STIs toward high-Socio-demographic Index (SDI) countries. Epidemiological changes were the primary driver of burden trends. By 2036, the ASMR for HIV\/AIDS and STIs is projected to decline by 82.9%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Drug use is a critical, evolving driver of infectious disease burden. Stratified interventions and coordinated supply\u2013demand-side governance are essential to mitigate this burden and achieve global health goals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1706764","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:27:19Z","timestamp":1765780039000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global burden and forecast of infectious diseases attributable to drug use: evidence from GBD 2021"],"prefix":"10.3389","volume":"13","author":[{"given":"Xueqing","family":"Gong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanqian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kairui","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"key":"ref1","volume-title":"Global hepatitis report 2024: action for access in low- and middle-income countries","year":"2024"},{"key":"ref2","volume-title":"HIV data and statistics","year":"2024"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1093\/infdis\/jiaa432","article-title":"Infectious diseases and injection drug use: public health burden and response","volume":"222","author":"Levitt","year":"2020","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"603615","DOI":"10.3389\/fimmu.2020.603615","article-title":"Indicator regularized non-negative matrix factorization method-based drug repurposing for COVID-19","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jiph.2023.04.014","article-title":"Efficacy and mortality of ceftazidime\/avibactam-based regimens in carbapenem-resistant gram-negative bacteria infections: a retrospective multicenter observational study","volume":"16","author":"Zhuang","year":"2023","journal-title":"J Infect Public Health"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2263229","DOI":"10.1080\/21645515.2023.2263229","article-title":"An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination","volume":"19","author":"Zhang","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"105779","DOI":"10.1016\/j.ypmed.2019.105779","article-title":"Sexual risk behaviors and STDs among persons who inject drugs: a national study","volume":"126","author":"Brookmeyer","year":"2019","journal-title":"Prev Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"144","DOI":"10.15585\/mmwr.mm6806a4","article-title":"Increased methamphetamine, injection drug, and heroin use among women and heterosexual men with primary and secondary syphilis \u2013 United States, 2013-2017","volume":"68","author":"Kidd","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.mcna.2021.08.006","article-title":"Infectious complications of injection drug use","volume":"106","author":"Marks","year":"2022","journal-title":"Med Clin North Am"},{"key":"ref10","volume-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030 (2022)","year":""},{"key":"ref11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","article-title":"Ending the HIV Epidemic: A Plan for the United States","volume":"321","author":"Fauci","year":"2019","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1097\/00002030-199408000-00017","article-title":"Injecting drug use and HIV infection in Southwest China","volume":"8","author":"Zheng","year":"1994","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e2454455","DOI":"10.1001\/jamanetworkopen.2024.54455","article-title":"Recent incarceration and HIV risk among women who use heroin","volume":"8","author":"Atkins","year":"2025","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1588607","DOI":"10.3389\/fpubh.2025.1588607","article-title":"Global, regional and national burden of drug use disorders, 1990-2021: decomposition analysis, health inequality analysis and predictions to 2035","volume":"13","author":"Jin","year":"2025","journal-title":"Front Public Health"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s00127-023-02587-w","article-title":"Drug-use disorders in the eastern Mediterranean region: a glance at GBD 2019 findings","volume":"59","author":"Amirkafi","year":"2024","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"102328","DOI":"10.1016\/j.eclinm.2023.102328","article-title":"Burden and risk factors of mental and substance use disorders among adolescents and young adults in Kenya: results from the global burden of disease study 2019","volume":"67","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1109\/TCBB.2021.3059046","article-title":"A dual ranking algorithm based on the multiplex network for heterogeneous complex disease analysis","volume":"19","author":"Li","year":"2022","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(24)00933-4","article-title":"Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1186\/s12859-020-03682-4","article-title":"NEDD: a network embedding based method for predicting drug-disease associations","volume":"21","author":"Zhou","year":"2020","journal-title":"BMC Bioinformat"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.3390\/diagnostics13111923","article-title":"Short-term forecasting of Monkeypox cases using a novel filtering and combining technique","volume":"13","author":"Iftikhar","year":"2023","journal-title":"Diagnostics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain \u2014 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11904-019-00437-6","article-title":"Scaling-up PrEP delivery in sub-Saharan Africa: what can we learn from the scale-up of ART?","volume":"16","author":"O\u2019Malley","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(18)31311-4","article-title":"HIV","volume":"392","author":"Ghosn","year":"2018","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S2468-1253(19)30085-8","article-title":"The contribution of injecting drug use as a risk factor for hepatitis C virus transmission globally, regionally, and at country level: a modelling study","volume":"4","author":"Trickey","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(07)60315-8","article-title":"Evolution of China\u2019s response to HIV\/AIDS","volume":"369","author":"Wu","year":"2007","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ssmph.2018.06.007","article-title":"The rise and fall of mortality inequality in South Africa in the HIV era","volume":"5","author":"Haal","year":"2018","journal-title":"SSM Popul Health"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jadohealth.2016.03.014","article-title":"Sexually transmitted infection Services for Adolescents and Youth in low- and middle-income countries: perceived and experienced barriers to accessing care","volume":"59","author":"Newton-Levinson","year":"2016","journal-title":"J Adolesc Health"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/sj.cr.7290360","article-title":"Injection drug use and HIV\/AIDS transmission in China","volume":"15","author":"Chu","year":"2005","journal-title":"Cell Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.15585\/mmwr.mm7347a3","article-title":"Progress toward UNAIDS global HIV pre-exposure prophylaxis targets: CDC-Supported Oral pre-exposure prophylaxis \u2014 37 countries, 2017\u25002023","volume":"73","author":"Peck","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/S2468-1253(21)00267-3","article-title":"New WHO guidance for country validation of viral hepatitis B and C elimination","volume":"6","author":"Easterbrook","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1620371","DOI":"10.3389\/fmed.2025.1620371","article-title":"Global, regional, and national burden of acute hepatitis (1990-2021): a systematic analysis of the global burden of disease in 2021","volume":"12","author":"Bai","year":"2025","journal-title":"Front Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.70132","article-title":"Trends in acute hepatitis B among people living with HIV over 25\u202fyears: incidence and clinical outcomes","author":"Arcos-Rueda","year":"2025","journal-title":"HIV Med"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e807","DOI":"10.1016\/S2352-3018(24)00212-1","article-title":"Global, regional, and national burden of HIV\/AIDS, 1990-2021, and forecasts to 2050, for 204 countries and territories: the global burden of disease study 2021","volume":"11","year":"2024","journal-title":"Lancet HIV"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/07853890.2021.2022188","article-title":"Awareness, perception and utilization of a mobile health clinic by people who use drugs","volume":"54","author":"Grieb","year":"2022","journal-title":"Ann Med"},{"key":"ref37","volume-title":"WHO Model Lists of Essential Medicines. (2025)","year":""},{"key":"ref38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.15585\/mmwr.mm6808a2","article-title":"Progress toward hepatitis B control and elimination of mother-to-child transmission of hepatitis B virus \u2013 Western Pacific region, 2005-2017","volume":"68","author":"Woodring","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"ofab641","DOI":"10.1093\/ofid\/ofab641","article-title":"Association of tumor necrosis factor \u03b1 inhibitor use with diagnostic features and mortality of tuberculosis in the United States, 2010-2017","volume":"9","author":"Katrak","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12889-024-21187-0","article-title":"Forecasting cardiovascular disease mortality using artificial neural networks in Sindh, Pakistan","volume":"25","author":"Qureshi","year":"2025","journal-title":"BMC Public Health"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1377\/hlthaff.2025.00418","article-title":"Improving Policy Evaluations Of The Opioid Crisis","volume":"44","author":"Pacula","year":"2025","journal-title":"Health Aff (Millwood)"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"20552076231204748","DOI":"10.1177\/20552076231204748","article-title":"A hybrid forecasting technique for infection and death from the mpox virus","volume":"9","author":"Iftikhar","year":"2023","journal-title":"Digital Health"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3390\/diagnostics13071310","article-title":"On the implementation of the artificial neural network approach for forecasting different healthcare events","volume":"13","author":"Alshanbari","year":"2023","journal-title":"Diagnostics"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12954-023-00861-3","article-title":"Availability of telehealth-based services at syringe services programs under the COVID-19 public health emergency","volume":"20","author":"Bartholomew","year":"2023","journal-title":"Harm Reduct J"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e64829","DOI":"10.2196\/64829","article-title":"Application of machine learning and emerging health Technologies in the Uptake of HIV testing: bibliometric analysis of studies published from 2000 to 2024","volume":"14","author":"Jaiteh","year":"2025","journal-title":"Interact J Med Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"403","year":"2024","journal-title":"Lancet"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1706764\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T06:27:21Z","timestamp":1765780041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1706764\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":46,"alternative-id":["10.3389\/fpubh.2025.1706764"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1706764","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"article-number":"1706764"}}